TRENDSPOTTER: The Right Kind of Genomics Partnership | GenomeWeb

TO BE honest, as a venture capitalist I am a little bit bored with the simple “me-too” concepts companies have been presenting lately and the onslaught of press releases that hail new alliances between big pharma and small biotech companies. All of these deals have one thing in common: they entail enormous investments from the big company into the small company, revealing the continued dependence of the biotech companies on the larger corporate sponsors they serve.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.